No Data
No Data
Earnings Preview: ADCT to Report Financial Results Pre-market on May 14
$ADC Therapeutics(ADCT.US)$ is scheduled to release its financial results pre-market on May 14 ET. Earnings PreviewAnalysts estimate $ADC Therapeutics(ADCT.US)$ to post revenue of USD17.71M for 2025Q1
ADC Therapeutics SA (ADCT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
ADC Therapeutics Shares Are Trading Higher After the Company Announced Data From Preclinical Studies of Three Exatecan-based Antibody Drug Conjugates Targeting Claudin-6, Prostate-specific Membrane Antigen and Alanine, Serine, Cysteine Transporter 2
ADC Therapeutics' Claudin-6 Targeting ADC Shows Strong Single-Agent And Combination Potential In Solid Tumors
ADC Therapeutics Announces Preclinical Data Highlighted at the American Association for Cancer Research Annual Meeting 2025
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan